Hemoglobin-derived peptides as novel type of bioactive signaling molecules.
Most bioactive peptides are generated by proteolytic cleavage of large precursor proteins followed by storage in secretory vesicles from where they are released upon cell stimulation. Examples of such bioactive peptides include peptide neurotransmitters, classical neuropeptides, and peptide hormones. In the last decade, it has become apparent that the breakdown of cytosolic proteins can generate peptides that have biological activity. A case in point and the focus of this review are hemoglobin-derived peptides. In vertebrates, hemoglobin (Hb) consists of a tetramer of two α- and two β-globin chains each containing a prosthetic heme group, and is primarily involved in oxygen delivery to tissues and in redox reactions (Schechter Blood 112:3927-3938, 2008). The presence of α- and/or β-globin chain in tissues besides red blood cells including rodent and human brain and peripheral tissues (Liu et al. Proc Natl Acad Sci USA 96:6643-6647, 1999; Newton et al. J Biol Chem 281:5668-5676, 2006; Wride et al. Mol Vis 9:360-396, 2003; Setton-Avruj Exp Neurol 203:568-578, 2007; Ohyagi et al. Brain Res 635:323-327, 1994; Schelshorn et al. J Cereb Blood Flow Metab 29:585-595, 2009; Richter et al. J Comp Neurol 515:538-547, 2009) suggests that globins and/or derived peptidic fragments might play additional physiological functions in different tissues. In support of this hypothesis, a number of Hb-derived peptides have been identified and shown to have diverse functions (Ivanov et al. Biopoly 43:171-188, 1997; Karelin et al. Neurochem Res 24:1117-1124, 1999). Modern mass spectrometric analyses have helped in the identification of additional Hb peptides (Newton et al. J Biol Chem 281:5668-5676, 2006; Setton-Avruj Exp Neurol 203:568-578, 2007; Gomes et al. FASEB J 23:3020-3029, 2009); the molecular targets for these are only recently beginning to be revealed. Here, we review the status of the Hb peptide field and highlight recent reports on the identification of a molecular target for a novel set of Hb peptides, hemopressins, and the implication of these peptides to normal cell function and disease. The potential therapeutic applications for these Hb-derived hemopressin peptides will also be discussed.
Gomes
Ivone
I
Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York 10029, USA.
Dale
Camila S
CS
Casten
Kimbie
K
Geigner
Miriam A
MA
Gozzo
Fabio C
FC
Ferro
Emer S
ES
Heimann
Andrea S
AS
Devi
Lakshmi A
LA
D000595:Amino Acid Sequence; D000818:Animals; D006454:Hemoglobins / Q000737:chemistry*; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000494:pharmacology*; D015398:Signal Transduction; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D006454:Hemoglobins; D010455:Peptides
Physiol Res. 2004;53(6):603-7
15588127
Peptides. 2005 Mar;26(3):431-6
15652650
Pharmacol Rev. 1994 Sep;46(3):269-91
7831381
Peptides. 2006 Nov;27(11):2957-66
16904236
Biochem Biophys Res Commun. 1998 May 29;246(3):719-24
9618278
Can J Physiol Pharmacol. 1995 Sep;73(9):1235-45
8748972
Peptides. 2006 Dec;27(12):3331-40
17097762
Nat Rev Mol Cell Biol. 2009 Feb;10(2):148-55
19122676
J Biol Chem. 1999 Feb 5;274(6):3363-71
9920878
Am J Physiol. 1997 Apr;272(4 Pt 1):E600-6
9142880
Br J Pharmacol. 2003 Apr;138(8):1431-40
12721098
Peptides. 2009 Feb;30(2):256-61
19061927
Nat Rev Neurosci. 2008 Nov;9(11):826-38
18931696
Exp Neurol. 2007 Feb;203(2):568-78
17126834
Eur J Neurosci. 2008 Aug;28(3):588-98
18702730
Peptides. 1989 Jul-Aug;10(4):747-51
2587417
Peptides. 2003 Aug;24(8):1201-6
14612192
Biochem Int. 1986 Mar;12(3):379-83
3011001
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53
9600986
Curr Opin Immunol. 2009 Feb;21(1):84-91
19261456
Peptides. 1998;19(4):759-66
9622033
J Comp Neurol. 2009 Aug 10;515(5):538-47
19479992
FEBS Lett. 1983 May 8;155(2):281-4
6852239
J Neurochem. 2003 Jul;86(2):344-50
12871575
Biotechnol Appl Biochem. 2001 Dec;34(3):173-81
11730485
Biochem Biophys Res Commun. 1992 Nov 30;189(1):101-10
1449465
Bull Exp Biol Med. 2006 Feb;141(2):223-5
16984102
Mol Vis. 2003 Aug 22;9:360-96
12942050
Eur J Pharmacol. 1986 Jun 17;125(2):309-10
3743640
Biopolymers. 1997;43(2):147-56
9216251
Brain Res Bull. 1990 Sep;25(3):407-10
2292037
Front Biosci. 2002 Apr 01;7:d997-1006
11897565
Biochem Pharmacol. 1986 Dec 15;35(24):4499-503
3024652
FEBS Lett. 1999 Mar 19;447(1):81-6
10218587
Biotechnol Appl Biochem. 1999 Dec;30(3):201-7
10574688
Peptides. 2001 Dec;22(12):1999-2008
11786183
Brain Res Bull. 1995;37(3):223-6
7627564
J Neurochem. 2007 Aug;102(3):967-76
17504262
Annu Rev Biochem. 2002;71:537-92
12045106
Nat Med. 2008 Aug;14(8):837-42
18568035
Nature. 2002 Apr 4;416(6880):535-9
11932745
J Am Soc Nephrol. 2008 Aug;19(8):1500-8
18448584
J Biol Chem. 1993 Jul 25;268(21):15405-11
8393440
Peptides. 1998;19(1):119-31
9437744
Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15454-9
19717439
FEBS J. 2007 Jan;274(2):474-84
17229152
Peptides. 2005 Aug;26(8):1317-22
16042973
Life Sci. 1992;51(11):869-85
1355851
Arch Int Pharmacodyn Ther. 1957 Sep 1;111(4):409-19
13471093
J Neurosci. 2010 May 26;30(21):7369-76
20505104
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6643-7
10359765
J Vet Med A Physiol Pathol Clin Med. 2005 May;52(4):162-5
15882399
Protein Pept Lett. 2003 Aug;10(4):386-95
14529492
J Biol Chem. 2007 Feb 23;282(8):5116-24
17148456
Biopharm Drug Dispos. 2007 Mar;28(2):73-85
17173283
Neurobiol Learn Mem. 2009 Jul;92(1):19-26
19233301
Neuropharmacology. 1983 Feb;22(2):191-6
6835487
Brain Res. 1981 Sep 21;221(1):161-9
7272759
J Neurochem. 2009 Dec;111(6):1425-33
20050289
Neuropharmacology. 2001 Mar;40(4):618-23
11249971
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20588-93
18077343
J Biol Chem. 2006 Mar 3;281(9):5668-76
16407281
FASEB J. 2009 Sep;23(9):3020-9
19380512
Peptides. 2006 Sep;27(9):2082-9
16730859
Neuropeptides. 1996 Feb;30(1):1-5
8868292
J Biol Chem. 2003 Mar 7;278(10):8547-55
12500972
Biotechnol Appl Biochem. 2004 Apr;39(Pt 2):199-208
15032740
Peptides. 2006 Sep;27(9):2284-8
16713023
Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:105-6
15962106
Neuroscience. 2004;124(2):341-9
14980384
Peptides. 1997;18(2):293-300
9149303
Annu Rev Pharmacol Toxicol. 2008;48:393-423
18184105
Behav Brain Res. 2004 Sep 23;154(1):239-43
15302130
J Neurosci Res. 2004 Mar 1;75(5):704-14
14991846
J Neurosci. 2009 Aug 26;29(34):10582-7
19710311
Peptides. 2002 Aug;23(8):1465-70
12182948
Biochimie. 2004 Jan;86(1):31-7
14987798
J Biol Chem. 2001 Dec 28;276(52):48623-6
11707427
Neurol Res. 2005 Dec;27(8):869-81
16354549
Neurosci Biobehav Rev. 1996 Autumn;20(3):341-58
8880728
FASEB J. 2009 May;23(5):1287-302
19174475
J Neurosci. 2006 Oct 25;26(43):10967-83
17065439
J Neurochem. 1997 Jun;68(6):2530-7
9166749
Biosci Biotechnol Biochem. 2002 May;66(5):1130-2
12092829
Eur J Biochem. 2001 Jun;268(11):3259-66
11389728
Cell Mol Life Sci. 2004 Nov;61(21):2728-37
15549174
FEBS Lett. 1993 Jul 12;326(1-3):215-8
8391997
Neurosci Behav Physiol. 2003 Jun;33(5):521-8
12921184
J Neurochem. 1999 Jul;73(1):301-8
10386983
Biochem Biophys Res Commun. 2005 Aug 12;333(4):1348-52
15979582
J Cereb Blood Flow Metab. 2009 Mar;29(3):585-95
19116637
Peptides. 1987 Sep-Oct;8(5):905-9
3432136